G&H Showcases Photonics-Enabled Diagnostic Innovation at ESCMID 2026

April 2026 – Ashford, UK

G&H (LON:GHH), a global leader in life sciences manufacturing, optics, and photonics, will exhibit at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2026), taking place April 18–21 at Messe München in Munich, Germany.

Attendees can visit G&H at Hall B1, Booth #D12 to explore how the company enables next-generation infectious disease diagnostics through its vertically integrated medical device development capabilities, delivered through its life sciences business, G&H | ITL.

Enabling Precision at the Point of Diagnosis

As clinical microbiology laboratories face increasing pressure to deliver faster, more accurate, and more comprehensive diagnostic results, the role of photonics has become central to system performance.

From fluorescence-based assays to multiplexed molecular diagnostics, optical subsystems play a critical role in defining sensitivity, speed, and reproducibility - but only when integrated within well-engineered diagnostic instruments.

At ESCMID 2026, G&H will demonstrate how its expertise in photonics engineering and medical device design supports:

• High-sensitivity optical detection for low-volume and complex samples
• Precise wavelength control for multiplexed and multi-parametric assays
• Stable optical and mechanical alignment under real-world operating conditions
• Robust signal acquisition and processing in low-noise environments
• Scalable system design for high-throughput laboratory workflows

From Concept to Clinical Deployment

With decades of experience supporting diagnostic OEMs, G&H offers a fully integrated capability set that spans the entire product lifecycle:

• Feasibility and optical system architecture
• Design for manufacture (DFM) and rapid prototyping
• Precision optics and photonics integration
• Injection molding and consumables production
• ISO:13485-certified manufacturing and regulatory support

This approach has enabled G&H to support diagnostic OEMs in translating complex optical technologies into clinically deployable systems - improving signal fidelity, reducing time-to-market, and ensuring reliable performance in regulated laboratory environments.

“We work with our customers at the system level, not just the component level,” said Tom Ackrill, Senior Business Development Manager at G&H. “In clinical diagnostics, performance is defined by how well every element works together - from optical precision to manufacturability. That’s where our integrated approach makes a real difference.”